Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia

The contribution of genetic factors to the age at onset in multiple sclerosis is poorly understood. Our objective was to investigate the disease modifying effects of HLA-DRB1 alleles and allele interactions on age at onset of multiple sclerosis. High-resolution four-digit HLA-DRB1 genotyping was performed in a cohort of 461 multiple sclerosis patients from the Perth Demyelinating Diseases Database. Carriage of the HLA-DRB1*1501 risk allele was not significantly associated with age at onset but HLA-DRB1*0801 was associated with a later onset of the disease. The HLA-DRB1*0401 allele was associated with a reduced age at onset when combined with DRB1*1501 but may delay age at onset when combined with DRB1*0801. These findings indicate that epistatic interactions at the HLA-DRB1 locus have significant modifying effects on age at onset of multiple sclerosis and demonstrate the value of high-resolution genotyping in detecting such associations.

[1]  J. Byrnes,et al.  Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis , 2009, Journal of Human Genetics.

[2]  A. Sadovnick,et al.  Age of Onset in Concordant Twins and Other Relative Pairs With Multiple Sclerosis , 2009, American journal of epidemiology.

[3]  F. Christiansen,et al.  34. Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort , 2009, Journal of clinical neuroscience.

[4]  K. Wittkowski,et al.  An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene , 2009, BMC Medical Genetics.

[5]  D. Reich,et al.  Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. , 2009, Archives of neurology.

[6]  Arne Svejgaard,et al.  The immunogenetics of multiple sclerosis , 2008, Immunogenetics.

[7]  A. Kermode,et al.  Characterisation of the spectrum of demyelinating disease in Western Australia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  G. Ebers.  Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[9]  T. Hudson,et al.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus , 2007, Proceedings of the National Academy of Sciences.

[10]  M. Feolo,et al.  14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes. , 2007, Tissue antigens.

[11]  S. Poduslo,et al.  APOE genotypes in African American female multiple sclerosis patients , 2007, Neuroscience Letters.

[12]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[13]  Pablo Villoslada,et al.  Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. , 2006, Human molecular genetics.

[14]  S. Vukusic,et al.  Age at disability milestones in multiple sclerosis. , 2006, Brain : a journal of neurology.

[15]  Vincent Ferretti,et al.  A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis , 2005, Nature Genetics.

[16]  M. Z. Cader,et al.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. , 2005, Human molecular genetics.

[17]  R. Nelson,et al.  HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population , 2004, Multiple sclerosis.

[18]  J. Hillert,et al.  HLA‐DR15 and age at onset in multiple sclerosis , 2002, European journal of neurology.

[19]  S. Sawcer,et al.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[20]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[21]  H. Harbo,et al.  Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis , 2000, Journal of the Neurological Sciences.

[22]  J. Hillert,et al.  HLA‐DR15 is associated with lower age at onset in multiple sclerosis , 2000, Annals of neurology.

[23]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999 .

[24]  Z. Meiner,et al.  HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. , 1999, Archives of neurology.

[25]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[26]  D. Miller,et al.  The natural history of multiple sclerosis: a regional study with some longitudinal data. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[27]  S. Hauser,et al.  Multiple sclerosis sibling pairs , 1990, Neurology.

[28]  G. Beebe,et al.  Epidemiology of multiple sclerosis in US veterans , 1985, Neurology.

[29]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[30]  A. Verma,et al.  Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study , 2008 .

[31]  F. Christiansen,et al.  HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. , 2001, Tissue antigens.

[32]  T. Welborn.  The Busselton Study. Mapping population health. Cardiovascular and respiratory diseasea risk factors , 1998 .

[33]  J. Kurtzke,et al.  Epidemiology of multiple sclerosis in US veterans. 4. Age at onset. , 1992, Neuroepidemiology.